Calprotectin (S100A8/9) as serum biomarker for clinical response in proof-of-concept trials in axial and peripheral spondyloarthritis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6354
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Calprotectin (S100A8/9) as serum biomarker for clinical response in proof-of-concept trials in axial and peripheral spondyloarthritis ; volume:16 ; number:4 ; day:19 ; month:8 ; year:2014 ; pages:1-9 ; date:8.2014
Arthritis Research & Therapy ; 16, Heft 4 (19.8.2014), 1-9, 8.2014
- Creator
-
Turina, Maureen C.
- Contributor
-
Yeremenko, Nataliya
Paramarta, Jacqueline E.
De Rycke, Leen
Baeten, Dominique
SpringerLink (Online service)
- DOI
-
10.1186/s13075-014-0413-4
- URN
-
urn:nbn:de:1111-201605191176
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Turina, Maureen C.
- Yeremenko, Nataliya
- Paramarta, Jacqueline E.
- De Rycke, Leen
- Baeten, Dominique
- SpringerLink (Online service)
Other Objects (12)
Association of circulating calprotectin with lipid profile in axial spondyloarthritis
Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis
Work Disability in Axial Spondyloarthritis
P190: Cardiovascular Disease in Axial Spondyloarthritis
Novel Therapeutic Targets in Axial Spondyloarthritis
Targeting inflammatory pathways in axial spondyloarthritis
Evaluation of Intestinal S100/calgranulin (S100A8/A9 and S100A12) Expression and Fecal Calprotectin (S100A8/A9) in Cats with Chronic Enteropathies
Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapy
Decreased fecal calprotectin levels in Spondyloarthritis patients colonized by Blastocystis spp
The prevalence of fibromyalgia in axial spondyloarthritis
Nonradiographic axial spondyloarthritis: clinical and therapeutic relevance
Diagnosis, monitoring, and management of axial spondyloarthritis
Association of circulating calprotectin with lipid profile in axial spondyloarthritis
Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis
Work Disability in Axial Spondyloarthritis
P190: Cardiovascular Disease in Axial Spondyloarthritis
Novel Therapeutic Targets in Axial Spondyloarthritis
Targeting inflammatory pathways in axial spondyloarthritis
Evaluation of Intestinal S100/calgranulin (S100A8/A9 and S100A12) Expression and Fecal Calprotectin (S100A8/A9) in Cats with Chronic Enteropathies
Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapy
Decreased fecal calprotectin levels in Spondyloarthritis patients colonized by Blastocystis spp
The prevalence of fibromyalgia in axial spondyloarthritis
Nonradiographic axial spondyloarthritis: clinical and therapeutic relevance
Diagnosis, monitoring, and management of axial spondyloarthritis
Association of circulating calprotectin with lipid profile in axial spondyloarthritis
Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis
Work Disability in Axial Spondyloarthritis
P190: Cardiovascular Disease in Axial Spondyloarthritis
Novel Therapeutic Targets in Axial Spondyloarthritis
Targeting inflammatory pathways in axial spondyloarthritis
Evaluation of Intestinal S100/calgranulin (S100A8/A9 and S100A12) Expression and Fecal Calprotectin (S100A8/A9) in Cats with Chronic Enteropathies
Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapy
Decreased fecal calprotectin levels in Spondyloarthritis patients colonized by Blastocystis spp
The prevalence of fibromyalgia in axial spondyloarthritis
Nonradiographic axial spondyloarthritis: clinical and therapeutic relevance